FDA plans crackdown on homeopathic drugs

(BY: JOSH HAFNER, USA TODAY) – A booming homeopathic industry prompted the Food and Drug Administration to announce a crackdown on potentially risky alternative remedies that now slip through its regulatory cracks.

The homeopathic drug market grew “exponentially” over the past decade into a nearly $3 billion industry, the FDA said, resulting in a flood of products manufactured without the agency’s approval.

New plans announced Monday place scrutiny on products aimed at children and infants as well as those marketed for life-threatening ailments like heart disease and cancer.

Click here to read more.